$3.32
-2.8%Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
Warren Buffett's Owner Earnings DCF analysis for intrinsic value calculation
Base year metrics used for projections
Forecast period and terminal assumptions
Calculation flow from present value to intrinsic value per share
Operating Cash Flow - Maintenance CapEx = Owner Earnings
| Metric | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | Year 6 | Year 7 | Year 8 | Year 9 | Year 10 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $383.4M | $766.8M | $1.5B | $3.1B | $6.1B | $12.3B | $24.5B | $49.1B | $98.2B | $196.3B |
| Maintenance CapEx | -$3.7M | -$7.4M | -$14.9M | -$29.8M | -$59.5M | -$119.0M | -$238.1M | -$476.2M | -$952.3M | -$1.9B |
| Owner Earnings | $379.7M | $759.4M | $1.5B | $3.0B | $6.1B | $12.1B | $24.3B | $48.6B | $97.2B | $194.4B |
| Discount Factor | 0.926 | 0.857 | 0.794 | 0.735 | 0.681 | 0.630 | 0.583 | 0.540 | 0.500 | 0.463 |
| Present Value | $351.6M | $651.0M | $1.2B | $2.2B | $4.1B | $7.7B | $14.2B | $26.3B | $48.6B | $90.0B |
Continue your EMBC research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.